Litcius/Paper detail

Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker For Small Bowel Mucosal Activity in Crohn’s Disease

Ami Kawamoto, K Takenaka, Shuji Hibiya, Kazuo Ohtsuka, Ryuichi Okamoto, Mamoru Watanabe

2021Clinical Gastroenterology and Hepatology48 citationsDOI

Topics & Concepts

MedicineBiomarkerUlcerative colitisCrohn's diseaseGlycoproteinInflammatory bowel diseaseGastroenterologyDiseaseInternal medicineCrohn diseaseBiochemistryBiologyClusterin in disease pathologyInflammatory Bowel DiseaseGenetic factors in colorectal cancer
Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker For Small Bowel Mucosal Activity in Crohn’s Disease | Litcius